Featured
-
-
Nature Podcast |
Coronapod: COVID boosters amidst global vaccine inequity
Should wealthy nations give booster shots when billions remain unvaccinated?
- Noah Baker
- & Amy Maxmen
-
News Feature |
Has COVID taught us anything about pandemic preparedness?
Researchers warn that plans to prevent the next global outbreak don’t consider the failures that have fuelled our current predicament.
- Amy Maxmen
-
News |
How do vaccinated people spread Delta? What the science says
Emerging data suggest that Delta could spread more readily than other coronavirus variants among people vaccinated against COVID-19. But key questions remain.
- Nidhi Subbaraman
-
News Round-Up |
Deer infections, vaccination nudges and predicting ‘breakthrough’ COVID cases
The latest science news, in brief.
-
News |
Remember Beta? New data reveal variant’s deadly powers
People infected with a variant first identified in South Africa are more likely to die than those infected with other variants.
- Ewen Callaway
-
Correspondence |
Call to update US re-entry rules for international researchers
- Alice Braga
- , Valerio Francioni
- & Gabrielle String
-
Comment |
Use HIV’s lessons to help children orphaned by COVID-19
Young people who have lost parents to the pandemic need urgent support and long-term study to avert the cascade of adversity that can follow. Decades of research into the HIV epidemic provide a solid foundation.
- Rachel Kidman
-
News Q&A |
Chelsea Clinton urges global sharing of COVID vaccine technology
The health-policy specialist who grew up in the White House is using her training and connections to convince world leaders to help make vaccines accessible to all nations.
- Amy Maxmen
-
Nature Podcast |
Coronapod: Ivermectin, what the science says
More controversy plagues this would-be COVID treatment as influential study is withdrawn
- Noah Baker
- & Sara Reardon
-
News |
COVID vaccine inequity, species swaps — the week in infographics
Nature highlights three key infographics from the week in science and research.
-
News |
Delta threatens rural regions that dodged earlier COVID waves
Data on the variant’s spread in India make researchers fearful for areas in developing nations that lack health care and vaccines.
- Smriti Mallapaty
-
News Feature |
COVID vaccine boosters: the most important questions
Concerns over waning immunity and SARS-CoV-2 variants have convinced some countries to deploy extra vaccine doses — but it’s not clear to scientists whether most people need them.
- Ewen Callaway
-
News Round-Up |
COVID vaccine enthusiasm, astronomy bullies and an enzyme chip
The latest science news, in brief.
-
Article |
Microbes exploit death-induced nutrient release by gut epithelial cells
Intestinal microorganisms exploit nutrients released by apoptotic gut epithelial cells for growth.
- Christopher J. Anderson
- , Christopher B. Medina
- & Kodi S. Ravichandran
-
World View |
Cash payments in Africa could boost vaccine uptake
When doses finally arrive, use cash incentives to overcome hesitancy.
- Rabah Arezki
-
News |
Surprise dip in UK COVID cases baffles researchers
Daily recorded infections have more than halved since mid-July. Few researchers anticipated such a sharp decline, and they are now struggling to interpret it.
- Philip Ball
-
News |
COVID ‘Fast Grants’ sped up pandemic science
Programme awarded US$50 million in rapid grants and highlights limitations in existing scientific-funding mechanisms.
- Holly Else
-
News |
The coronavirus is rife in common US deer
Survey results show that many white-tailed deer, a familiar sight on US lawns and golf courses, have antibodies to the virus that causes COVID-19.
- Smriti Mallapaty
-
Career Feature |
Pandemic upheaval offers a huge natural experiment
The disruption that the coronavirus has caused to daily life has created unique research opportunities for scientists.
- Julia Rosen
-
Book Review |
The COVID vaccine makers tell all
A book from the Oxford–AstraZeneca team, and a documentary, go behind the scenes in the race to vaccinate the world.
- Heidi Ledford
-
News & Views |
Text-message nudges encourage COVID vaccination
A field trial shows that text-message ‘nudges’ encourage people to get vaccinated against COVID-19. To be effective, nudge approaches such as this must combine three aspects: they must prompt, enable and motivate behaviour.
- Mitesh S. Patel
-
News |
Flawed ivermectin preprint highlights challenges of COVID drug studies
The study’s withdrawal from a preprint platform deals a blow to the anti-parasite drug’s chances as a COVID treatment, researchers say.
- Sara Reardon
-
News |
A simple text has the power to increase COVID vaccinations
People who received a short ‘nudge’ by mobile phone were more likely to get a jab than were those who did not.
- Max Kozlov
-
Career Column |
We need to talk about post-pandemic lectures
Off-campus learning was essential during the pandemic. But when it ends, we should encourage students to return to campus for in-person lectures, says Michael Doran.
- Michael Doran
-
News |
COVID boosters for wealthy nations spark outrage
Nations short of vaccine should get first doses to curb the pandemic, researchers say.
- Amy Maxmen
-
Research Highlight |
Your blood teems with a unique set of stealthy ‘anelloviruses’
A single individual harbours tens to hundreds of variants of this DNA-based virus, which can move from one person to another in donated blood.
-
News |
A blood marker predicts who gets ‘breakthrough’ COVID
Real-world evidence from a medical centre links high levels of potent antibodies after vaccination to a reduced risk of infection.
- Smriti Mallapaty
-
Article |
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians
The microbiota of centenarians (aged 100 years and older) comprise gut microorganisms that are capable of generating unique secondary bile acids, including isoallolithocholic acid, a bile acid with potent antimicrobial effects against Gram-positive—but not Gram-negative—multidrug-resistant pathogens.
- Yuko Sato
- , Koji Atarashi
- & Kenya Honda
-
News Feature |
How the coronavirus infects cells — and why Delta is so dangerous
Scientists are unpicking the life cycle of SARS-CoV-2 and how the virus uses tricks to evade detection.
- Megan Scudellari
-
News Round-Up |
Delta’s success, satellite swarms and a ‘super’ COVID antibody
The latest science news, in brief.
-
Article
| Open AccessRapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine
Longitudinal analyses of SARS-CoV-2 mRNA vaccine-elicited epitope-specific CD8+ T cell responses shows that CD8+ T cells are rapidly induced after prime vaccination and stably maintained after boost vaccination.
- Valerie Oberhardt
- , Hendrik Luxenburger
- & Maike Hofmann
-
Correspondence |
Peru to punish bending of clinical-trial rules
- Cesar Cabezas-Sanchez
- , Yamilee Hurtado-Roca
- & Victor Suárez-Moreno
-
World View |
Remember Ebola: stop mass COVID deaths in Africa
The wealthy world must rally or nations will collapse across Africa.
- Mosoka Fallah
-
News |
COVID vaccines slash viral spread – but Delta is an unknown
Studies show that vaccines reduce the spread of SARS-CoV-2 by more than 80%, but the Delta variant is creating fresh uncertainty.
- Smriti Mallapaty
-
Nature Podcast |
Coronapod: the latest on COVID and sporting events
As the Olympics kick off, data on the impact of large sporting events is still limited, despite large research efforts
- Noah Baker
- & Holly Else
-
News |
COVID and mass sport events: early studies yield limited insights
The United Kingdom allowed mass gatherings and attempted to study them, but the early results provide limited data on viral transmission.
- Holly Else
-
News |
COVID vaccines have higher approval in less-affluent countries
Surveys show that people in ten low- and middle-income nations are generally more eager to receive the COVID-19 jab than are people in two wealthier nations where vaccine is plentiful.
- Max Kozlov
-
News |
How the Delta variant achieves its ultrafast spread
Viral load is roughly 1,000 times higher in people infected with the Delta variant than those infected with the original coronavirus strain, according to a study in China.
- Sara Reardon
-
News Round-Up |
Inflammation clock, mini vaccine dose and genome editing
The latest science news, in brief.
-
Career Column |
How to manage the uncertainty of a remote PhD
Satheesh Kumar has found ways to be productive without ever visiting his supervisor or lab.
- Satheesh Kumar
-
News Explainer |
Should children get COVID vaccines? What the science says
With vaccination campaigns under way in some countries while others weigh the options, Nature looks at the evidence for vaccinating younger people.
- Heidi Ledford
-
News |
These archaeologists helped quell a COVID surge in Madagascar
As a wave of infections threatened rural communities, the scientists stepped in to fund and distribute aid.
- Megan Scudellari
-
Article |
Broad sarbecovirus neutralization by a human monoclonal antibody
The human monoclonal antibody S2X259 cross-reacts with spike proteins from all clades of sarbecovirus, and provides prophylactic and therapeutic protection in vivo against parental SARS-CoV-2 and emerging variants of concern.
- M. Alejandra Tortorici
- , Nadine Czudnochowski
- & Matteo Samuele Pizzuto
-
Nature Podcast |
Coronapod: does England's COVID strategy risk breeding deadly variants?
Researchers are alarmed at England's plan to lift COVID restrictions on 'freedom day' amidst soaring infections
- Noah Baker
- & Philip Ball
-
News |
Massive DNA ‘Borg’ structures perplex scientists
Researchers say they have discovered unique and exciting DNA strands in the mud — others aren’t sure of their novelty.
- Amber Dance
-
News |
The US is boosting funding for research monkeys in the wake of COVID
The investments are promising but won’t fix the primate shortage, experts say.
- Nidhi Subbaraman
-
News |
This ‘super antibody’ for COVID fights off multiple coronaviruses
An newly identified immune molecule raises hopes for a vaccine against a range of viruses related to SARS-CoV-2.
- Diana Kwon
-
News & Views |
Deciphering metabolism, one microbe at a time
Small molecules produced and modified by gut microorganisms can influence human physiology. An atlas of metabolic outputs of diverse gut microbes offers new ways to decipher the microbial mechanisms behind their production.
- William F. Kindschuh
- & Tal Korem
-
Outlook |
Research round-up: autoimmune disease
Links between COVID-19 and autoimmunity, a better model of coeliac disease, and other highlights from clinical trials and laboratory studies.
- Laura Vargas-Parada
Browse broader subjects
Browse narrower subjects
- Antimicrobials
- Applied microbiology
- Archaea
- Bacteria
- Bacteriology
- Bacteriophages
- Biofilms
- Biogeochemistry
- Cellular microbiology
- Clinical microbiology
- Microbial communities
- CRISPR-Cas systems
- Environmental microbiology
- Fungi
- Industrial microbiology
- Infectious-disease diagnostics
- Microbial genetics
- Parasitology
- Pathogens
- Phage biology
- Policy and public health in microbiology
- Vaccines
- Virology